0001477932-21-007866.txt : 20211105
0001477932-21-007866.hdr.sgml : 20211105
20211105160557
ACCESSION NUMBER: 0001477932-21-007866
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211103
FILED AS OF DATE: 20211105
DATE AS OF CHANGE: 20211105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TERRELL JASON BRADLEY MD
CENTRAL INDEX KEY: 0001567531
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36833
FILM NUMBER: 211384521
MAIL ADDRESS:
STREET 1: 13215 BEE CAVE PARKWAY, SUITE 125,
STREET 2: GALLERIA OAKS B
CITY: AUSTIN
STATE: TX
ZIP: 78738
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VOLITIONRX LTD
CENTRAL INDEX KEY: 0000093314
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 911949078
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13215 BEE CAVE PARKWAY
STREET 2: GALLERIA OAKS B, SUITE 125
CITY: AUSTIN
STATE: TX
ZIP: 78738
BUSINESS PHONE: 1 (646) 650-1351
MAIL ADDRESS:
STREET 1: 13215 BEE CAVE PARKWAY
STREET 2: GALLERIA OAKS B, SUITE 125
CITY: AUSTIN
STATE: TX
ZIP: 78738
FORMER COMPANY:
FORMER CONFORMED NAME: STANDARD CAPITAL CORP
DATE OF NAME CHANGE: 19990812
4
1
form4.xml
FORM 4
X0306
4
2021-11-03-05:00
false
0000093314
VOLITIONRX LTD
VNRX
0001567531
TERRELL JASON BRADLEY MD
13215 BEE CAVE PARKWAY, SUITE 125
GALLERIA OAKS B
AUSTIN
TX
78738
false
true
false
false
Chief Medical Officer
Stock Option (Right to Buy)
4.00
2021-11-03-05:00
4
D
false
25000
D
2017-04-15-05:00
2022-04-15-05:00
Common Stock
25000
0
D
Stock Option (Right to Buy)
4.00
2021-11-03-05:00
4
A
false
25000
A
2017-04-15-05:00
2026-04-15-05:00
Common Stock
25000
25000
D
Stock Option (Right to Buy)
5.00
2021-11-03-05:00
4
D
false
50000
D
2018-03-30-05:00
2023-03-30-05:00
Common Stock
50000
0
D
Stock Option (Right to Buy)
5.00
2021-11-03-05:00
4
A
false
50000
A
2018-03-30-05:00
2027-03-30-05:00
Common Stock
50000
50000
D
Stock Option (Right to Buy)
4.00
2021-11-03-05:00
4
D
false
50000
D
2019-01-23-05:00
2024-01-23-05:00
Common Stock
50000
0
D
Stock Option (Right to Buy)
4.00
2021-11-03-05:00
4
A
false
50000
A
2019-01-23-05:00
2028-01-23-05:00
Common Stock
50000
50000
D
The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on April 15, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on April 15, 2026 (ten years from the original date of grant).
The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant).
The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant).
/s/ Jason Terrell MD
2021-11-05-05:00